US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 7.760
  • +0.030+0.39%
Close Feb 14 16:00 ET
151.57MMarket Cap-5.33P/E (TTM)

About Actuate Therapeutics Company

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Company Profile

SymbolACTU
Company NameActuate Therapeutics
Listing DateAug 13, 2024
Issue Price8.00
Founded2015
CEOMr. Daniel M. Schmitt
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1751 River Run,Suite 400
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76107
Phone1-817-887-8455
Websitehttp://www.actuatetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel M. Schmitt
  • President, Chief Executive Officer and Director
  • 520.00K
  • Dr. Andrew P. Mazar, PhD
  • Chief Operating Officer
  • 666.11K
  • Paul J. Lytle
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Aaron G.L. Fletcher, PhD
  • Chairman of the Board
  • 23.29K
  • Leslie W. Kreis, Jr
  • Independent Director
  • 23.29K
  • Amy L. Ronneberg
  • Independent Director
  • --
  • Jason A. Keyes
  • Independent Director
  • --
  • Dr. Dan Zabrowski, PhD
  • Independent Director
  • 23.29K
  • Dr. Roger Sawhney
  • Independent Director
  • --
  • Todd S. Thon
  • Independent Director
  • 23.29K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Earnings Season Underway
Earnings season is here. What to know?